Consolidated Statements Of Cash Flows (USD $) In Thousands, unless otherwise specified	9 Months Ended
	Sep. 30, 2014	Sep. 30, 2013
Operating activities:
Net income	$ 15,131	$ 10,603
Adjustments to reconcile net income to net cash provided by operating activities:
Provision for loan losses	(4,238)	(707)
Adjustments to other real estate	320	1,970
Deferred tax expense	8,100	6,043
Asset depreciation	1,930	1,802
Securities premium amortization, net of discount accretion	2,004	2,793
Amortization of intangibles	588	1,037
Restricted stock amortization expense	636	647
Net gain on sales/calls of investment securities	(764)
Net gain on sales of mortgage loans	(1,069)	(2,264)
Net (gain) loss on sales of premises/equipment	36	(7)
Net gain on sales of other real estate	(200)	(3,880)
Net gain from sale of bank branches	(4,378)
Proceeds from sales of held for sale loans	59,088	109,493
Held for sale loans originated for resale	(55,137)	(106,148)
Net changes in assets and liabilities:
Accrued interest receivable	82	640
Other assets	(3,322)	28,501
Accrued interest payable	(74)	(276)
Other liabilities	692	(2,759)
Net cash provided by operating activities	19,425	47,488
Investing activities:
Proceeds from sales of available for sale securities		2,744
Held to maturity securities	1,750	5,000
Available for sale securities	58,517	90,406
Redemptions of other investments	883	382
Purchases of held to maturity securities		(5,000)
Purchases of available for sale securities	(34,833)	(107,995)
Loans originated, net of principal repayments	(131,198)	64,609
Cash outflows from sale of bank branches, net	(94,806)
Purchases of premises and equipment	(1,581)	(1,455)
Proceeds from sales of premises and equipment	68	68
Proceeds from sales of other real estate	1,306	16,107
Net cash provided by (used in) investing activities	(199,894)	64,866
Financing activities:
Net increase (decrease) in deposits	41,435	(125,787)
Net increase (decrease) in other borrowings	(4,748)	8,301
Net proceeds from issuance of common stock	83	194
Purchases of treasury stock	(3,678)
Repurchase of common stock warrant		(2,287)
Redemption of trust preferred securities		(35,570)
Common stock dividends paid	(2,358)
Preferred stock dividends paid	(1)
Net cash provided by (used in) financing activities	30,733	(155,149)
Net decrease in cash and cash equivalents	(149,736)	(42,795)
Cash and cash equivalents:
Beginning of period	279,839	288,079
End of period	$ 130,103	$ 245,284